Jump Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

Jump Financial’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$707K	Buy	+22,500	New	+$664K	0.01%	1335
2025 Q1	–	Sell	-14,074	Closed	-$294K	–	1647
2024 Q4	$294K	Sell	14,074 -20,867	-60%	-$448K	0.01%	1311
2024 Q3	$695K	Buy	+34,941	New	+$648K	0.01%	973
2024 Q1	–	Sell	-64,122	Closed	-$1.08M	–	1949
2023 Q4	$1.08M	Buy	64,122 +32,138	+100%	+$439K	0.03%	678
2023 Q3	$374K	Buy	31,984 +14,715	+85%	+$197K	0.01%	1179
2023 Q2	$232K	Sell	17,269 -139,453	-89%	-$2.01M	0.01%	1449
2023 Q1	$2.6M	Buy	156,722 +77,393	+98%	+$1.28M	0.11%	301
2022 Q4	$1.48M	Buy	79,329 +31,829	+67%	+$490K	0.08%	337
2022 Q3	$609K	Sell	47,500 -34,401	-42%	-$408K	0.02%	813
2022 Q2	$574K	Sell	81,901 -21,593	-21%	-$158K	0.02%	791
2022 Q1	$858K	Sell	103,494 -18,906	-15%	-$134K	0.04%	583
2021 Q4	$829K	Buy	+122,400	New	+$805K	0.05%	455
2021 Q3	–	Sell	-37,983	Closed	-$219K	–	1157
2021 Q2	$219K	Sell	37,983 -17,117	-31%	-$88.3K	0.02%	817
2021 Q1	$254K	Buy	+55,100	New	+$219K	0.02%	671
2020 Q4	–	Sell	-52,500	Closed	-$156K	–	979
2020 Q3	$156K	Buy	+52,500	New	+$205K	0.03%	660

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jump Financial's CPRX Position: Q2 2026 in Review

Jump Financial opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 22,500 shares worth $707K. The stake represents 0.01% of the portfolio and ranks #1335 among its holdings. This is a return to the name: Jump Financial previously reported a position in CPRX as recently as Q4 2024.

Jump Financial first reported a position in CPRX in Q3 2020 and has held it in 15 quarters since. The position peaked at $2.6M in Q1 2023. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Jump Financial held 22,500 shares of Catalyst Pharmaceutical worth $707K as of Q2 2026.
Catalyst Pharmaceutical was a new Jump Financial position in Q2 2026.
Catalyst Pharmaceutical made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1335 holding.
Jump Financial first reported a position in Catalyst Pharmaceutical in Q3 2020 and has held it in 15 quarters since.
Jump Financial's Catalyst Pharmaceutical position peaked at $2.6M in Q1 2023.
396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.